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Letter to the Editor 
A Phosphotyrosine Interaction Domain 
A major step in the understanding of signal transduction 
came with the realization that Src homology 2 (SH2) do- 
mains bind peptide sequences containing phosphotyro- 
sine (Pawson and Schlessinger, 1993). Shc is an SH2 
domain protein that becomes tyrosine phosphorylated 
after activation of cells by various cytokines and growth 
factors. This phosphorylation enables Shc to bind to Grb2, 
coupling Shc to the Ras activation pathway (Rozakis- 
Adcock et al., 1992). Surprisingly, Kavanaugh and Wil- 
liams (1994) as well as our group (Blaikie et al., 1994) have 
recently identified a region in Shc distinct from the SH2 
domain that can also bind tyrosine-phosphorylated pro- 
teins. This region appears structurally unrelated to SH2 
domains and may impart on Shc its unique ability to bind 
to the Asn-Pro-X-Tyr(P) motif found in many tyrosine- 
phosphorylated proteins, including growth factor recep- 
tors (Obermeier et al., 1993; Stephens et al., 1994; Camp- 
bell et al., 1994). 
The minimum binding domain of the amino terminus of 
Shc that can mediate phosphotyrosine-dependent i terac- 
tions has been defined as amino acids 46-209 of the 52 
kDa form of Shc (Blaikie et al., 1994). We have subjected 
this region of Shc and a related protein, Sck (Kavanaugh 
and Williams, 1994), to various data base search methods 
(Koonin et al., 1994) in order to identify other proteins that 
might contain homologous domains. Indeed, we were able 
to retrieve nine distinct proteins (Figures 1 and 2) that 
contained a similar domain, several of which have been 
sequenced in different organisms. We propose the name 
PID (for phosphotyrosine interaction domain) for this pro- 
tein-protein interaction motif. The average length of the 
PID is about 160 amino acids, but it can vary considerably. 
Structural predictions suggest that it is a globular domain, 
and the arrangement of the helices and I~ strands indicates 
the presence of an antiparallel I~ sheet (Figure 1). Although 
all the sequences share common features such as hy- 
drophobicity patterns and conserved motifs, only two 
positions appear to be invariant (Gly-58 and Ser-151 of 
p52 Shc). 
The biochemical data obtained with the PID of Shc indi- 
cate that it may have a general role in tyrosine kinase 
signal transduction. This is supported by the identification 
of a PID in Disabled, a tyrosine-phosphorylated protein 
found in Drosophila (Gertler et al., 1993). A mouse gene 
encoding a mitogen-responsive phosphoprotein with a 
PID very similar to Disabled was also found in the Gen Ban k 
data base (accession number U18869; p96 in Figures 1 
and 2), as was a partial sequence of a putative human 
ortholog (Mok et al., 1994; DOC-2 in Figure 1). Another 
member of the PID family, numb, has not been suspected 
to be part of a tyrosine kinase signaling pathway but has 
an important role in determining cell fates in the Drosophila 
nervous system (Rhyu et al., 1994). 
The Xl l  gene was originally isolated as a candidate 
gene for Friedreich ataxia (Duclos et al., 1993). Its PID 
has the closest sequence similarity to those of Sck and 
Shc (29% sequence identity). The X l l  proteins contain 
two successive disc homologous region (DHR) repeats of 
about 100 amino acids downstream of the PID (Figure 2). 
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Figure 1. Sequence Alignments of the PID 
Initial data base searches with the putative 
binding domains of Shc and Sck were per- 
formed using the BLAST series of programs 
(Altschul et al., 1994, and references therein). 
F56D2.1, X11, and numb had scores indicative 
of a homology (probability of matching by 
chance, p < 0.03). Their consistent alignments 
(i.e., they all matched the same regions of the 
query protein) prompted a detailed analysis. 
Additional BLAST runs with the candidate se- 
quences using PROFILE (Gribskov et al., 
1987), as well as iterative motif searches (Tatu- 
sov et al., 1994) with the four most conserved 
blocks (marked in the figure), confirmed the 
similarity and identified the remaining proteins 
of the set. For example, F56D2.1 and Disabled 
or p96 have significant BLASTP p values of 
<3.3 x 10 -6. Furthermore, all sequences 
match each of the blocks independently with 
high significance as computed using MOST 
(Tatusov et al., 1994); e.g., all sequences 
match block 2, with probabilities of occurring 
by chance of p < 1 x 10 8. The consensus is indicated on the top line: capital letters, highly conserved residues; h, hydrophobic; a, aromatic; t, 
polar/turnlike; minus, acidic residues. White letters on black background denote residues conserved in more than 50% of the proteins. Stippled 
residues underline the hydrophobic or aromatic nature of a position in agreement with the consensus. Predicted secondary (two-dimensional) 
structures (Rost and Sander, 1994) are indicated by h (helices) and b (13 strands). Dashes and numbers in brackets indicate gaps in the alignment. 
The accession numbers for the proteins are listed at the far right. The sequence for Sck has not been deposited and is derived from the literature 
(Kavanaugh and Williams, 1994). FE65 has an amino-terminal (N) and carboxy-terminal (C) PID. 
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Figure 2. Schematic Representation of Proteins Containing a PID 
The domains represented are these: DHR (Ponting and Philip, 1995), 
WW (Bork and Sudol, 1994), SH2 (Pawson and Schlessinger, 1993), and 
i nsulinase-like metallopeptidase (Rawlings and Barrett, 1991). Compo- 
sitionally biased and probably nonglobular segments such as proline- 
rich regions, as indicated by the program SEG (Wootton, 1994), are 
shown by thick lines. Species names in parentheses indicate the pres- 
ence of partial sequences in the data base (mostly ESTs) that appear 
to represent orthologs of these proteins. The numbers to the far right 
indicate the number of amino acids in the proteins; Disabled, p96, 
and FE65 appear to have alternatively spliced forms. The dashed lines 
indicate that only fragments have been sequenced. 
The DHR domain was first found in several proteins that 
localize at postsynaptic, septate, and tight junctions, but 
its presence in various other intracellular signaling pro- 
teins is now established (Ponting and Philip, 1995). FE65 
was originally proposed as a transcriptional activator (Dui- 
lio et al., 1991). However, the presence of a WW domain 
(Figure 2; Bork and Sudol, 1994) as well as two PIDs sug- 
gests that it is likely to be involved in signal transduction. 
F56D2.1 is a putative gene identified in the Caenorhabditis 
elegans genome sequencing project (Wilson et al., 1994) 
that contains an amino-terminal metalloprotease domain. 
Various expressed sequence tags (ESTs) cover parts of 
the PID, but, with the exception of human Est05045, they 
seem to encode the previously identified genes with PIDs 
from other species. Nevertheless, these ESTs demon- 
strate a broad species range and a considerable expres- 
sion level, and their degree of sequence similarity indi- 
cates conservation of the domain during evolution. 
The presence of the PID in several otherwise unrelated 
regulatory proteins suggests a general role for this domain 
in protein-protein interactions and signal transduction. 
The exact binding preference of the different PIDs needs 
to be determined experimentally, but it is tempting to spec- 
ulate that proteins containing PIDs are involved in tyrosine 
kinase signaling pathways. 
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